FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097492 [Registered on: 17/11/2025] Trial Registered Prospectively
Last Modified On: 17/11/2025
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Effect of local anaesthesia medicine as steam on heart during nose operations. 
Scientific Title of Study   A randomized comparative clinical trial to study the effect of 4 percent lignocaine nebulization and 10 percent lignocaine spray on intraoperative hemodynamics for intranasal surgeries under general anaesthesia. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Domala Radhika 
Designation  Assisstant professor 
Affiliation  esic medical college 
Address  Room number 3021, anaesthesia department, 3rd floor , esic medical college,hyderabad.

Hyderabad
TELANGANA
500038
India 
Phone  9505032812  
Fax    
Email  domalaradhika@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Domala Radhika 
Designation  Assisstant professor 
Affiliation  esic medical college 
Address  Room number 3021, anaesthesia department, 3rd floor , esic medical college,hyderabad

Hyderabad
TELANGANA
500038
India 
Phone  9505032812  
Fax    
Email  domalaradhika@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Domala Radhika 
Designation  Assisstant professor 
Affiliation  esic medical college 
Address  Room number 3021, anaesthesia department, 3rd floor , esic medical college,hyderabad.

Hyderabad
TELANGANA
500038
India 
Phone  9505032812  
Fax    
Email  domalaradhika@gmail.com  
 
Source of Monetary or Material Support  
Esic medical college,hyderabad, Room number 3021, anaesthesia department, 3rd floor . 500038 
 
Primary Sponsor  
Name  esic medical college 
Address  Room number 3021, anaesthesia department, 3rd floor , esic medical college,hyderabad 500038  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Domala radhika  Operation theatre complex ,3rd floor  Room number 3021, anaesthesia department, 3rd floor , esic medical college,hyderabad.
Hyderabad
TELANGANA 
9505032812

domalaradhika@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ESIC medical college and hospital and ESIC superspeciality hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J329||Chronic sinusitis, unspecified, (2) ICD-10 Condition: J329||Chronic sinusitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  0.9 percent normal saline  patients receive 0.9 percent normal saline 2.5ml via nebulisation 15 minutes before induction in the pre operative area . 
Intervention  10 percent lignocaine spray  patients receive 5 puffs of 10 percent topical lignocaine spray in each nostril at 2mg/kg (10mg per puff) 15 minutes before induction in the preoperative area  
Intervention  4 percent lignocaine nebulization  Patients receive 4 percent lignocaine hydrochloride through nebulization at 2mg/kg (2.5ml containing 100mg for a patient with 50kg weight)given 15 min before induction in the preoperative area  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  American society of anesthesiologists 1,2.
valid written informed consent
patient undergoing intranasal surgeries.
 
 
ExclusionCriteria 
Details  American society of Anesthesiologists 3,4
drug allergies
bleeding disorders
patient refusal
pregnancy


 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Changes in Heart rate (HR) and Mean arterial pressure (MAP).  o,5,15,30,45,60,90,120,150 minutes  
 
Secondary Outcome  
Outcome  TimePoints 
To compare surgical field score, post operative analgesia.  0,4,12,24 hours 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   01/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Intranasal surgeries encompass a diverge range of procedures performed within nasal cavity to address structural  ,funtional or pathological conditions .These surgeries including septoplasty ,endoscopic sinus surgery and turbinate reduction are integral in managing conditions such as chronic rhinosinusitis ,nasal obstruction ,deviated nasal septum .It is essential to provide adequate pain management in patients who undergo intranasal surgery. Due to the great vascularity of the nasal mucosa the main concern with intranasal surgeries is intranasal bleeding compromising visibility of surgical field which may further lead to damage of vascular structures, endoscope entering intracranial space ,entering into orbit ,increased duration of surgery ,major blood loss .Local anesthetics  directly act on nasal mucosa and also block sphenopalatine ganglion  so we planned a study to compare the intraoperative hemodynamics with 4 percent lignocaine nebulization and 10 percent lignocaine spray for intranasal surgeries under general  anesthesia.

 
Close